Addyi was first authorised with the FDA in August 2015 to treat hypoactive sexual drive problem (HSDD) in premenopausal Ladies. Which is just another way of claiming it boosts sex travel (also referred to as libido) in women which have not attained menopause. It had been the first these drug https://bostanli.yesilyurtcilingir.net/